HOME >> BIOLOGY >> NEWS
Treatment protects mouse ovaries from radiation therapy

Study may lead to ways to preserve fertility in women undergoing cancer treatment

A team of researchers from the Massachusetts General Hospital (MGH), Memorial Sloan-Kettering Cancer Center in New York, and other research centers has found a molecule that, in animal studies, has blocked the destruction of ovarian egg cells (oocytes) by radiation therapy. The report in the October issue of Nature Medicine describes how a compound called sphingosine-1-phosphate (S1P), which blocks the activity of a cell-death-associated molecule called ceremide, preserved ovarian egg cells and fertility in female mice exposed to levels of radiotherapy that otherwise would have destroyed their ovaries. The researchers expect that the same protection would be afforded to ovaries exposed to chemotherapeutic drugs.

"For the first time we have a promising prospect for a small molecule that could be given to women and girls undergoing cancer treatment to protect their ovaries," says Jonathan Tilly, PhD, the paper's senior author. However, he notes that further research needs to be completed before trials of S1P could be attempted in human patients.

All mammalian females are born with a huge supply of immature egg cells that is depleted throughout their lives by a process called programmed cell death or apoptosis. Only a tiny fraction of the oocytes a female is born with actually mature and are released from the ovaries as eggs. It has long been known that treatment with chemotherapy drugs and radiation therapy can accellerate the death of oocytes, resulting in premature menopause and infertility among many women and young girls who are treated for cancer.

In previous research, Tilly's team at the MGH Vincent Center for Reproductive Biology had shown that oocytes were destroyed by chemotherapy through a particular cell-death pathway involving the interaction of three principal signs called ceramide, Bax and caspase-2. They also showed that knocking out
'"/>

Contact: Susan McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
1-Oct-2000


Page: 1 2 3

Related biology news :

1. St. Petersburg/New Haven Partnership for HIV/AIDS Care, Treatment and Support launched
2. Treatment stimulates growth and regeneration of injured adult skeletal muscle
3. Treatment of lupus in mice may point the way to human treatment
4. Treatment in mice proves effective against Duchenne muscular dystrophy
5. National Institute on Drug Abuse launches National Drug Addiction Treatment Clinical Trials Network
6. Treatment restores normal heart rhythm in patients
7. Researchers Develop New Treatment For Hepatitis B And C As Nation Anticipates Surge In Number Of Cases
8. Researchers: Exciting Discovery Might Improve Cancer Treatment
9. Coffee Without Addiction, Possible New Treatment For Osteoporosis, Wrinkle-Free Cotton, And More
10. Scientists Discover Molecular Trigger Of Mucus Production, Suggesting First Treatment For Deadly Bronchitis, Other Diseases
11. Wistar Scientists Define Mechanism Of Action Used By Potential Magic Bullet In Cancer Treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it will host a roundtable ... National Harbor Hotel, Oxon Hill, Maryland, on April 10-12, 2019. , On Thursday, ...
(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem Cell ... its nationwide Centers of Excellence. R3 wants patients to feel secure when they ... protect patients from Centers that use inferior regenerative biologics, protocols or amounts, R3 ...
(Date:3/29/2019)... , ... March 28, 2019 , ... ... (PT) programme, a new PT programme entirely dedicated to Chinese biobanks was launched ... and Environmental Repositories (ISBER) and the Biobank Branch, China Medicinal Biotech Association (BBCMBA). ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive event series ... announces its Boston CEO conference to be held May 28-29, 2019 at Boston’s ... with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/27/2019)... ... , ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma ... and Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... cat, and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo ...
(Date:3/27/2019)... ... ... Lachman is sponsoring the event on April 1-4, where they will be ... team on site will be available to discuss strategies and tactics to support Facilities ... , Executives from Lachman participating at this year’s conference include Fran Zipp, President & ...
(Date:3/23/2019)... ... March 22, 2019 , ... ... Multi-Angle Light Scattering (MALS) detector , offering a revolutionary approach for the measurement ... proteins, and biopolymers. A novel optical design, a unique cell-block assembly, and a ...
Breaking Biology Technology:
Cached News: